AM281 T2264
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
AM 281, a cannabinoid antagonist, reduces neurologic dysfunction and mortality rate after cecal ligation and puncture in rats.
CAS nr:
202463-68-1
Purity:
98%
Molecular Weight:
557,21
SMILES:
Ic1ccc(c2n(nc(c2C)C(=O)NN2CCOCC2)c2c(Cl)cc(Cl)cc2)cc1
Formula:
C21H19Cl2IN4O2
Pathway:
GPCR/G Protein
Target:
Cannabinoid Receptor
